Angela Maria Sousa

Dr. Angela Maria Sousa

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2001 in Brain Research
Verified
Journal Article
Closed access
ASAngela Maria Sousa
Angela Maria Sousa
WPWiliam A. Prado
Wiliam A. Prado

1 November 2016 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
ASAngela Maria Sousa
Angela Maria Sousa
GRGiovanna M.C. Rosado
Giovanna M.C. Rosado
JNJose de S. Neto
Jose de S. Neto
GGGabriel M.N. Guimarães
Gabriel M.N. Guimarães
HAHazem A. Ashmawi
Hazem A. Ashmawi

1 March 1999 in Brain Research
Verified
Journal Article
Closed access
JRJ.-P Rivot
J.-P Rivot
ASAngela Maria Sousa
Angela Maria Sousa
JMJ Montagne-Clavel
J Montagne-Clavel
JBJ.-M Besson
J.-M Besson

1 February 2012 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
ASAngela Maria Sousa
Angela Maria Sousa
HAH.A. Ashmawi
H.A. Ashmawi
LCL.S. Costa
L.S. Costa
IPI.P. Posso
I.P. Posso
ASA. Slullitel
A. Slullitel
Local anesthetic efficacy of tramadol has been reported following intradermal application. Our aim was to investigate the effect of perineural tramadol as the sole analgesic in two pain models. Male Wistar rats (280-380 g; N = 5/group) were used in these experiments. A neurostimulation-guided sciatic nerve block was performed and 2% lidocaine or tramadol (1.25 and 5 mg) was perineurally injected in two different animal pain models. In the flinching behavior test, the number of flinches was evaluated and in the plantar incision model, mechanical and heat thresholds were measured. Motor effects of lidocaine and tramadol were quantified and a motor block score elaborated. Tramadol, 1.25 mg, completely blocked the first and reduced the second phase of the flinching behavior test. In the plantar incision model, tramadol (1.25 mg) increased both paw withdrawal latency in response to radiant heat (8.3 ± 1.1, 12.7 ± 1.8, 8.4 ± 0.8, and 11.1 ± 3.3 s) and mechanical threshold in response to von Frey filaments (459 ± 82.8, 447.5 ± 91.7, 320.1 ± 120, 126.43 ± 92.8 mN) at 5, 15, 30, and 60 min, respectively. Sham block or contralateral sciatic nerve block did not differ from perineural saline injection throughout the study in either model. The effect of tramadol was not antagonized by intraperitoneal naloxone. High dose tramadol (5 mg) blocked motor function as well as 2% lidocaine. In conclusion, tramadol blocks nociception and motor function in vivo similar to local anesthetics.

4 June 2015 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
HSH. B. G. da Silva
H. B. G. da Silva
ASAngela Maria Sousa
Angela Maria Sousa
GGG. M. N. Guimarães
G. M. N. Guimarães
ASA. Slullitel
A. Slullitel
HAH. A. Ashmawi
H. A. Ashmawi

14 July 2023 in Anaesthesia
Verified
Journal Article
Open access
TGT. R. Grigio
T. R. Grigio
HTHans Timmerman
Hans Timmerman
JMJ. V. B. Martins
J. V. B. Martins
ASA. Slullitel
A. Slullitel
AWAndré P. Wolff
André P. Wolff
ASAngela Maria Sousa
Angela Maria Sousa
Summary: Postoperative nausea or vomiting occurs in up to 40% in patients with multiple risk factors, despite prophylaxis. Olanzapine is an antipsychotic drug that is used to prevent nausea and vomiting in palliative care and to treat chemotherapy‐induced nausea and vomiting. This study aimed to examine whether pre‐operative olanzapine, as a prophylactic anti‐emetic added to intra‐operative dexamethasone, ondansetron and total intravenous anaesthesia, reduced the incidence of postoperative nausea or vomiting. We performed a multiply‐blinded randomised controlled trial in patients aged 18–60 years with cancer at high risk of postoperative nausea or vomiting (three or four risk factors according to the Apfel criteria) plus a previous history of chemotherapy‐induced nausea and vomiting. Patients were allocated at random to receive 10 mg olanzapine or placebo orally 1 h before surgery in addition to a two‐drug regimen (dexamethasone and ondansetron) and propofol anaesthesia to prevent postoperative nausea or vomiting. The primary outcome was the incidence of postoperative nausea or vomiting in the first 24 h after surgery. In total, 100 patients were enrolled; 47 in the olanzapine group and 49 in the control group completed the study. The baseline characteristics of the groups were similar. The incidence of postoperative nausea or vomiting in the first 24 h after surgery was lower in the olanzapine group (12/47, 26%) than in the control group (31/49, 63%) (p = 0.008, RR 0.40 (95%CI 0.21–0.79)). Adding pre‐operative oral olanzapine to intra‐operative dexamethasone and ondansetron was highly effective in reducing the risk of postoperative nausea or vomiting in the first 24 hours after surgery in patients with a previous history of chemotherapy‐induced nausea and vomiting and at least three Apfel risk factors for postoperative nausea or vomiting.